Bacterial persisters exhibit an extraordinary tolerance to antibiotics that is dependent on their metabolic state. Although persister metabolism promises to be a rich source of antipersister strategies, there is relatively little known about the metabolism of these rare and transient phenotypic variants. To address this knowledge gap, we explored the use of several techniques, and we found that only one measured persister metabolism. This assay was based on the phenomenon of metabolite-enabled aminoglycoside killing of persisters, and we used it to characterize the metabolic heterogeneity of different persister populations. From these investigations, we determined that glycerol and glucose are the most ubiquitously used carbon sources by various types of Escherichia coli persisters, suggesting that these metabolites might prove beneficial to deliver in conjunction with aminoglycosides for the treatment of chronic and recurrent infections. In addition, we demonstrated that the persister metabolic assay developed here is amenable to high-throughput screening with the use of phenotype arrays.
Persisters are phenotypic variants that are tolerant to extraordinary concentrations of antibiotics. Persisters in biofilms have been hypothesized to underlie the proclivity of biofilm infections to relapse (1), and until recently there was no effective way to eliminate persisters. Two promising studies have demonstrated metabolism-dependent killing of persisters: one that potentiates aminoglycoside (AG) activity by stimulating proton motive force generation in persisters (2), and another that stimulates persister awakening (3). These methods suggest that knowledge of persister metabolic capabilities would expedite the discovery and development of antipersister therapies. Consequently, perturbations to numerous metabolic genes and regulators have been shown to alter persister levels (4-9, 30, 31), further supporting a central role for metabolism in maintenance of this phenotypic state. In addition, persisters have recently been shown to largely adopt a metabolically quiescent state that must be achieved and sustained by coordinated metabolic actions (10). Unfortunately, persister metabolism has not been sufficiently studied, and knowledge of the metabolic activities of these phenotypic variants remains limited. In part, this is due to difficulties associated with isolation of persisters from normally growing cultures, where current techniques provide only modest persister enrichment (11,12).In this study, we sought to measure the metabolic activities of natively generated Escherichia coli persisters, not those obtained synthetically by overexpression of a toxin (13) or treatment with persister-stimulating agents (14). First, we attempted to use the only isolation technique previously described to produce pure persister samples (15). In this method, normally growing bacteria are lysed with ampicillin (AMP), and the remaining cells, considered persisters, are sedimented by centrifugation. However, by using LIVE/DEAD staining, a ...